Halozyme Therapeutics: The Losing Streak Continues (HALO)

Shares of Halozyme Therapeutics (NASDAQ:HALO) traded today at $7.49, breaking its 52-week low. So far today approximately 1.6 million shares have been exchanged, as compared to an average 30-day...